ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD), a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations, announced today that Richard Faleschini, President and Chief Executive Officer, is scheduled to present at the C.E. Unterberg, Towbin Emerging Growth Conference in New York City, on Tuesday, July 10, 2007 at 8:00 am Eastern Time. The Conference is being held at the Mandarin Oriental Hotel.
